Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Therapy for Carcinoma in Situ of the Bladder
- 1 December 1995
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 154 (6), 2050-2053
- https://doi.org/10.1016/s0022-5347(01)66691-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderThe New England Journal of Medicine, 1991
- Intravesical Chemotherapy (Mitomycin C) versus Immunotherapy (Bacillus Calmette-Guérin) in Superficial Bladder CancerEuropean Urology, 1991
- Comparison of Different Schedules of Cytostatic Intravesical Instillations in Patients with Superficial Bladder Carcinoma: Final Evaluation of a Prospective Multicenter Study with 419 PatientsJournal of Urology, 1990
- Intravesical Mitomycin C for Carcinoma in situ of the Urinary BladderScandinavian Journal of Urology and Nephrology, 1990
- Long-Term Results of Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder CancerJournal of Urology, 1989
- Long-Term Effect of Intravesical Bacillus Calmette-Guerin on Flat Carcinoma in Situ of the BladderJournal of Urology, 1986
- Immunotherapy of superficial bladder cancer with BCGWorld Journal of Urology, 1986
- Treatment of Superficial Bladder Cancer with Intravesical Mitomycin C: Analysis of Immediate and Long-Term Response in 70 PatientsJournal of Urology, 1985
- Intravesical cytostatics: pH-dependence of antitumour activityUrological Research, 1985
- Mitomycin Instillation to Prevent Recurrence of Superficial Bladder CarcinomaEuropean Urology, 1983